Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 21, 2008

Circulation. 2008
Published online before print July 21, 2008, doi: 10.1161/CIRCULATIONAHA.108.770883
A more recent version of this article appeared on August 5, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
118/6/614    most recent
CIRCULATIONAHA.108.770883v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prunier, F.
Right arrow Articles by del Monte, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prunier, F.
Right arrow Articles by del Monte, F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*Cardiomyopathy
*Genes and Gene Therapy
Related Collections
Right arrow Animal models of human disease
Right arrow Arrythmias-basic studies
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Electrocardiology
Right arrow Acute coronary syndromes
Right arrow Gene therapy
Right arrowRelated Article

Submitted on February 4, 2008
Accepted on May 21, 2008

Prevention of Ventricular Arrhythmias With Sarcoplasmic Reticulum Ca2+ ATPase Pump Overexpression in a Porcine Model of Ischemia Reperfusion

Fabrice Prunier MD, PhD, Yoshiaki Kawase MD, Davide Gianni BS, Cristina Scapin BS, Stephan B. Danik MD, Patric T. Ellinor MD, PhD, Roger J. Hajjar MD, and Federica del Monte MD, PhD*

From the Cardiovascular Research Center (F.P., D.G., C.S., P.T.E., F.d.M.), and Cardiac Arrhythmia Service (S.B.D., P.T.E.), Massachusetts General Hospital, Boston; Department of Gene and Cell Medicine, Mount Sinai Medical Center, New York, NY (Y.K., R.J.H.); and Dipartimento di Scienze Biomediche Sperimentali, University of Padova, Padova, Italy (C.S.).

* To whom correspondence should be addressed. E-mail: fdelmont{at}bidmc.harvard.edu.

Background—Ventricular arrhythmias are life-threatening complications of heart failure and myocardial ischemia. Increased diastolic Ca2+ overload occurring in ischemia leads to afterdepolarizations and aftercontractions that are responsible for cellular electric instability. We inquired whether sarcoplasmic reticulum Ca2+ ATPase pump (SERCA2a) overexpression could reduce ischemic ventricular arrhythmias by modulating Ca2+ overload.

Methods and Results—SERCA2a overexpression in pig hearts was achieved by intracoronary gene delivery of adenovirus in the 3 main coronary arteries. Homogeneous distribution of the gene was obtained through the left ventricle. After gene delivery, the left anterior descending coronary artery was occluded for 30 minutes to induce myocardial ischemia followed by reperfusion. We compared this model with a model of permanent coronary artery occlusion. Twenty-four–hour ECG Holter recordings showed that SERCA2a overexpression significantly reduced the number of episodes of ventricular tachycardia after reperfusion, whereas no significant difference was found in the occurrence of sustained or nonsustained ventricular tachycardia and ventricular fibrillation in pigs undergoing permanent occlusion.

Conclusions—We show that Ca2+ cycling modulation using SERCA2a overexpression reduces ventricular arrhythmias after ischemia-reperfusion. Strategies that modulate postischemic Ca2+ overload may have clinical promise for the treatment of ventricular arrhythmias.


Key words: arrhythmia • calcium • gene therapy • infarction • ischemia • reperfusion • sarcoplasmic reticulum


Related Article:

Clinical Summaries
Circulation 2008 118: 607-608. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Circ. Res.Home page
P. Nicolaou, P. Rodriguez, X. Ren, X. Zhou, J. Qian, S. Sadayappan, B. Mitton, A. Pathak, J. Robbins, R. J. Hajjar, et al.
Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury
Circ. Res., April 24, 2009; 104(8): 1012 - 1020.
[Abstract] [Full Text] [PDF]